96415 ⎘
Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides ; Anhydro-derivatives thereof
Sub-classes:TAGGED NUCLEOSIDE COMPOUNDS USEFUL FOR NANOPORE DETECTION
#2METHOD FOR THE SITE-SPECIFIC ENZYMATIC LABELLING OF NUCLEIC ACIDS IN VITRO BY INCORPORATION OF UNNATURAL NUCLEOTIDES
#3Method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides
#4METHODS AND COMPOSITIONS FOR INCORPORATING NUCLEOTIDES
#5METHODS AND COMPOSITIONS FOR INCORPORATING NUCLEOTIDES
#6METHODS AND COMPOSITIONS FOR INCORPORATING NUCLEOTIDES
#7INTEGRIN TARGETING LIGANDS AND USES THEREOF
#8CHIMERIC ANTIGEN RECEPTORS TARGETED TO PSCA
#9Crystalline forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoate
#105`S-LNA nucleotides and oligonucleotides
#11Compositions and methods for liquid phase oligonucleotide synthesis
#12Methods and compositions for incorporating nucleotides
#13SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
#14Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoate
#15Nucleotide analogues and use thereof for nucleic acid sequencing and analysis preliminary class
#16MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#17Tagged nucleoside compounds useful for nanopore detection
#18Chimeric antigen receptors targeted to PSCA
#19Methods and compositions for incorporating nucleotides
#20Methods and compositions for incorporating nucleotides
#21Method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides
#22Substituted nucleosides, nucleotides and analogs thereof
#23PHOSPHONATE ANALOGS OF HIV INHIBITOR COMPOUNDS
#24MODIFIED FLUORINATED NUCLEOSIDE ANALOGUES
#25Method of preparation of nanopore and uses thereof
#265′S-LNA nucleotides and oligonucleotides
#27Methods and compositions for incorporating nucleotides
#28Dinucleotides
#29Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5- (4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate
#30Methods and compositions for incorporating nucleotides
#31MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#32Protected monomer and method of final deprotection for RNA synthesis
#33Methods and compositions for incorporating nucleotides
#34Process for the cycloaddition of a halogenated 1,3-dipole compound with a (hetero)cycloalkyne
#35Method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides
#36Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
#37Protected monomer and method of final deprotection for RNA synthesis
#38Substituted nucleosides, nucleotides and analogs thereof
#39Method of preparation of nanopore and uses thereof
#40Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
#41Antiviral compounds
#42Compounds and pharmaceutical compositions for the treatment of viral infections
#43Anti-microbial agents and uses thereof
#44Synthesis of 5-deoxy-5′-fluorocytidine compounds
#45Modular functional peptides for the intracellular delivery of nanoparticles
#46Methods and compositions for incorporating nucleotides
#47Phosphonate analogs of HIV inhibitor compounds
#48Selective inhibitors of translesion DNA replication
#49Duplex oligonucleotide complexes and methods for gene silencing by RNA interference
#50Propargyl substituted nucleoside compounds and methods
#51Protected monomer and method of final deprotection for RNA synthesis
#52Modular system for organosolv fractionation of lignocellulosic feedstock
#53Novobiocin analogues having modified sugar moieties
#54MODIFIED FLUORINATED NUCLEOSIDE ANALOGUES
#55Continuous counter-current organosolv processing of lignocellulosic feedstocks
#56Synthesis of locked nucleic acid derivatives
#57Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
#58Modified nucleotides
#59Method for diagnosing acute lymphomic leukemia (ALL) using miR-125b
#60Method for diagnosing acute lymphomic leukemia (ALL) using miR-146a
#61Method for diagnosing acute lymphomic leukemia (ALL) using miR-222
#62Method for diagnosing acute lymphomic leukemia (ALL) using miR-221
#63Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
#64Compounds and pharmaceutical compositions for the treatment of viral infections
#65METHOD FOR THE FORMATION OF MEGAMITOCHONDRIA
#66Method for preparing nucleotides and related analogues by synthesis on soluble substrate, and biological tools thus prepared
#67Methods of treating cancer and other conditions or disease states using LFMAU and LDT
#68Modular functional peptides for the intracellular delivery of nanoparticles
#696-disubstituted or unsaturated bicyclic nucleic acid analogs
#70Modified fluorinated nucleoside analogues
#71CRYSTAL FORMS OF 2-[2-(4-CHLOROPHENYL)ETHOXY]ADENOSINE
#72MODIFIED 2' AND 3' NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#73Modified nucleotides
#74Inhibitors of S-adenosyl-L-methionine decarboxylase
#75-substituted-aminomethylene bridged bicyclic nucleic acid analogs
#76Synthesis of locked nucleic acid derivatives
#776-modified bicyclic nucleic acid analogs
#78METHOD OF PRODUCING NUCLEOSIDES
#79Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing
#80PROPARGYL SUBSTITUTED NUCLEOSIDE COMPOUNDS AND METHODS
#81Nucleoside analogs for antiviral treatment
#82Tripartite oligonucleotide complexes and methods for gene silencing by RNA interference
#83PROTECTED MONOMER AND METHOD OF FINAL DEPROTECTION FOR RNA SYNTHESIS
#84THIONUCLEOSIDES AND PHARMACEUTICAL APPLICATIONS
#85Stabilisation of radiopharmaceutical precursors
#86Chemically modified nucleoside 5′-triphosphates for thermally initiated amplification of nucleic acid
#87Modified nucleotides
#88Vesicles for use in biosensors
#892'-DEOXY-2'-FLUORO-BETA-D-ARABINONUCLEOSIDE 5'-TRIPHOSPHATES AND THEIR USE IN ENZYMATIC NUCLEIC ACID SYNTHESIS
#90Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of Disease
#91Nucleotide Compositions Comprising Photocleavable Markers And Methods Of Preparation Thereof
#92Tricyclic-Nucleoside Compounds for Treating Viral Infections
#93Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers
#94Compounds and Pharmaceutical Compositions for the Treatment of Viral Infections
#95Molecules for Gene Delivery and Gene Therapy, and Methods of Use Thereof
#96Tricyclic-Nucleoside Prodrugs for Treating Viral Infections
#97Phosphonate analogs of HIV inhibitor compounds
#98Novobiocin analogues
#99NUCLEOTIDE ANALOGS
#100Anti-microbial agents and uses thereof
#101Compounds and pharmaceutical compositions for the treatment of viral infections
#102Novobiocin analogues having modified sugar moieties
#103Continuous counter-current organosolv processing of lignocellulosic feedstocks
#104Nucleoside compounds and methods of use thereof
#105Continuous counter-current organosolv processing of lignocellulosic feedstocks
#106Selective inhibitors of translesion DNA replication
#107Chemically cleavable phosphoramidite linkers
#108MODIFIED FLUORINATED NUCLEOSIDE ANALOGUES
#109Nucleoside derivatives for treating hepatitis C virus infection
#1106-modified bicyclic nucleic acid analogs
#111Antiviral compounds
#112MODIFIED FLUORINATED NUCLEOSIDE ANALOGUES
#113Continuous counter-current organosolv processing of lignocellulosic feedstocks
#114CONTINUOUS COUNTER-CURRENT ORGANOSOLV PROCESSING OF LIGNOCELLULOSIC FEEDSTOCKS
#115Methods of treating cancer and other conditions or disease states using LFMAU and LDT
#116Compounds and pharmaceutical compositions for the treatment of viral infections
#117Methods and Compositions for Treating Flaviviruses, Pestiviruses and Hepacivirus
#118Compounds and pharmaceutical compositions for the treatment of liver disorders
#119MODIFIED FLUORINATED NUCLEOSIDE ANALOGUES
#1202′-silyl containing thiocarbonate protecting groups for RNA synthesis
#121Galactosyl nucleotide sugars
#122Protecting groups for RNA synthesis
#123Photolabile compound, oligomer probe array and substrate for oligomer probe array containing the same, and manufacturing method of the same
#124Phosphonate inhibitors of HCV
#125Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
#126Duplex oligonucleotide complexes and methods for gene silencing by RNA interference
#127Modified fluorinated nucleoside analogues
#128Nucleotide analogs
#129Methods and Compositions for Use in Preparing Hairpin Rnas
#130Nucleoside derivatives as inhibitors of rna-dependent RNA viral polymerase
#131Glucose transport inhibitors and methods of use
#132Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
#133PROCESS FOR PREPARING GEMCITABINE AND ASSOCIATED INTERMEDIATES
#1346-modified bicyclic nucleic acid analogs
#135Immunostimulatory nucleic acids
#136Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
#137Triphosphate oligonucleotide modification reagents and uses thereof
#138Modified nucleotides
#139Bis-indole pyrroles useful as antimicrobials agents
#140Nucleic acid sequencing methods, kits and reagents
#141Modified 2′ and 3′-nucleoside prodrugs for treating infections
#142Phosphonate analogs of HIV inhibitor compounds
#143Modified 2′ and 3′-nucleoside prodrugs for treating infections
#144Modified 2′ and 3′-nucleoside prodrugs for treating infections
#145Modified 2′ and 3′-nucleoside prodrugs for treating infections
#146Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections
#147Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
#148Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#149Modified 2′ and 3′-nucleoside prodrugs for treating infections
#150Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#151Stereoselective synthesis of β-nucleosides
#152Nucleoside derivative, modified oligonucleotide, method for their synthesis and applications thereof
#153Halogenated aminoquinolines and oligonucleotides containing the same
#154Process of making an alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonate and use thereof for making a beta nucleoside
#155Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
#156Nucleoside derivatives for treating Hepatitis C virus infection
#157Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
#158Tricyclic-nucleoside compounds for treating viral infections
#159Multiplex genotyping using solid phase capturable dideoxynucleotides and mass spectrometry
#160HIV gp41 HR2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus
#161Nucleoside compounds for treating viral infections
#162Hsp90 inhibitors, methods of making and uses therefor
#163Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
#164Tricyclic-nucleoside prodrugs for treating viral infections
#165Viral polymerase and modulation thereof
#166Compounds and processes for single-pot attachment of a label to nucleic acid
#167Process for manufacturing morpholino-nucleotides, and use thereof for the analysis of and labelling of nucleic acid sequences
#1682' -0-Trisubstituted silyloxymethyl-ribonucleoside-derivative and method for preparing the same
#169Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases
#170Method for the validated construction of arrays
#171Population of nucleic acids including a subpopulation of lna oligomers
#172Novel compounds for the treatment of sickle cell disease
#173Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine
#174Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof
#175Selective process for producing an anomer of a 1-phosphorylated saccharide derivative and process for producing a nucleoside
#176Nucleoside compounds for treating viral infections
#177Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine
#178UTR tag assay for gene function discovery
#179Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
#180Bis-indole pyrroles useful as antimicrobials agents
#181Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives
#182Propargyl substituted nucleoside compounds and methods
#183Propargyl substituted nucleoside compounds and methods
#184Nucleoside derivatives for treating hepatitis C virus infection
#185Nucleoside compounds for treating viral infections
#186Nucleoside compounds for treating viral infections
#187Process for manufacturing morpholino-nucleotides, and use thereof for the analysis of and labelling of nucleic acid sequences
#188Immunostimulatory nucleic acids
#189Precursors for two-step polynucleotide synthesis
#190Synthesis and compositions of 2'-terminator nucleotides
#191Anti-viral 7-deaza D-nucleosides and uses thereof
#192Modified fluorinated nucleoside analogues
#193Modified nucleotides and methods of labeling nucleic acids
#194Modified polynucleotides and uses thereof